Vice President - Bioproduct Analytical Development
CurrentAccountability for analytical development and control strategy extending from pre-clinical stage to commercial QC lab installation and global product registration for all of Lilly’s bioproducts, parenterally administered synthetic peptides and oligonucleotides, bioconjugates, gene therapy, and cell therapy. Manage and build department capabilities, including analytical control strategy, separation sciences, mass spectrometry, bioassay, biophysical characterization, corporate reference standards, and GMP Testing.